Medicine good momentum of development with an average annual profit growth of 20%

    

  Chinese herbal medicine is as raw material, processed into a variety of dosage forms formulations of traditional Chinese medicine products, clinical re-use, safe and effective dosage form fixed, and prepared to take a stable quality and reasonable process, controlled by the legally approved production into Fang Chinese medicine. With the development of Chinese medicine under the State Council issued the Strategic Plan (2016-2030) and Tu Yo Yo is eligible for stimulating medicine spillover effects caused by the Nobel Prize, Chinese herbal medicine industry usher in development opportunities.

Chinese medicine industry is one of the three pillar industries of Chinese medicine industry. With the rapid development of the pharmaceutical industry, the pharmaceutical industry in the country to promote the structural optimization and development, have introduced the standard, proprietary industry usher in the dividend policy to promote the development period. In the relevant regulations and policies to promote the support of the Chinese medicine industry the next few years will be explosive growth.

With the rapid development of China's economy over the years, the pharmaceutical industry has maintained a good momentum of development, especially since the reform and opening up, the rapid development of China's pharmaceutical industry, pharmaceutical industrial output value from 2009 9,946.00 billion to $ 25,798.00 in 2014 one hundred million yuan, an average annual compound growth rate of 20.61%. Higher than GDP growth, the national economy is one of the fastest growing industry, and medicine and the strongest growth in the pharmaceutical industry. With support for long-term development of Chinese medicine industry persistent population growth, aging, urbanization and other factors, it is expected that a steady growth of the Chinese medicine industry will continue.

In recent years, drugs fraud case and tourists to buy generic drugs in Japan and other news of frequent, gives rise to an illusion, especially the quality of our medicine medicine quality is not. Is it really? Through proprietary information-based medicine 360 one by one analysis, concluded that, from the means of control, the quality control of Chinese medicine-based medicine has done quite well, but there is room for improvement.

Future development of the industry needs to pay attention to the following aspects:

Chinese medicine market, high barriers to entry: It is estimated that a single registration of proprietary Chinese medicines cost about one million yuan on overseas markets, Chinese enterprises generally have a number of varieties, the application fee is relatively high. European Union "traditional herbal registration process instruction" provides traditional herbal prior to the filing date must be at least 30 years of medical history, including in the EU for at least 15 years of history of use, while the vast majority of domestic Chinese enterprises in Europe can not provide effective sales proof. Domestic strength is not strong and the lack of financial support for small businesses, because of the high cost of access to or can not meet the mandatory standards of the exporting country and difficult to open the international market.

SCIENCE serious shortage of investment capital. In the United States, according to the American Association of Pharmaceutical Research and Production Enterprise, he said the United States for pharmaceutical research and development costs of investment in 1997 was $ 21.1 billion in 2012 to $ 145 617 700 000 over the same period China's pharmaceutical enterprises to invest in research for medicine $ 45 billion, only US 30.90%. Lead to less research funding in the field of short-board presence of pharmaceutical companies to develop new products, patents, technology research, standards development, deal with technical trade measures to enhance the level of competitiveness of Chinese exports lack of stamina.

Pharmaceutical industry in order to upgrade should be brave to embrace the Internet, the Internet + New Ecology, industrial distribution business strategy is a very important part of the map, we should be thinking about how to create customer value, how business customers, and how to develop new channels, how to pass value of the produ